Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400093800Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in hypopnea and anoxemia comparing Propofol + Oliceridine with Propofol + Fentanyl (2 arms). Primary endpoint: Incidence of hypoxemia. Planned start Dec 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400093800.